Tag: IL-17RA

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

byNeel Mistryand1 others

May 5, 2021

1. At 12 weeks, the proportion of patients with an IGA score of 0 or 1 was significantly greater in ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

High-frequency oscillatory ventilation may reduce the incidence of bronchopulmonary dysplasia in neonatal respiratory distress syndrome
NeoCol trial: Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer
Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

No Result

View All Result